Braxia Scientific Corp C.BRAX

Alternate Symbol(s): BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.

CSE:BRAX - Post by User

Braxia Scientific Corp > Proposed Settlement in Class Action Lawsuit Against Braxia

<< Previous

Bullboard Posts

Next >>

Comment by KNDlawon May 10, 2022 6:50pm

183 Views

Post# 34672290

RE:Proposed Settlement in Class Action Lawsuit Against Braxia

Good day all,

Due to a conflict that arose in the schedule of the Supreme Court of British Columbia, the hearing for approval of the proposed settlement in the class action against Braxia Scientific Corp. has been moved from July 15, 2022 to July 18, 2022.

Further information about the proposed settlement is available at: https://knd.law/class-actions/braxia-scientific-corp/

Best,
KND Complex Litigation

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant